NCT06075147View on ClinicalTrials.gov

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

RecruitingOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

October 30, 2027

Study Completion Date

January 31, 2028

Conditions
Visual ImpairmentNeovascular Age-related Macular Degeneration (nAMD)Diabetic Macula Edema (DME)
Interventions
DRUG

Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

Following the manner of observational study, no intervention will be provided in the study. Any treatment decision, including the decision for aflibercept 8 mg treatment, is at the discretion of the attending physician, made in accordance with his/her experience and follows approved clinical guidelines.

Trial Locations (18)

Unknown

RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

RECRUITING

Many Locations, Multiple Locations

RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

RECRUITING

Many Locations, Multiple Locations

RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

RECRUITING

Many Locations, Multiple Locations

ACTIVE_NOT_RECRUITING

Many Locations, Multiple Locations

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT06075147 - The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema | Biotech Hunter | Biotech Hunter